CUSIP: 75901B107
Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
50,868,756
-
Total 13F shares
-
42,074,510
-
Share change
-
-1,433,073
-
Total reported value
-
$325,173,475
-
Put/Call ratio
-
55%
-
Price per share
-
$7.73
-
Number of holders
-
175
-
Value change
-
-$15,537,348
-
Number of buys
-
88
-
Number of sells
-
94
Quarterly Holders Quick Answers
What is CUSIP 75901B107?
CUSIP 75901B107 identifies RGNX - REGENXBIO Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Institutional Holders of REGENXBIO Inc. - Common Stock (RGNX) as of Q4 2024
As of 31 Dec 2024,
REGENXBIO Inc. - Common Stock (RGNX) was held by
175 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,074,510 shares.
The largest 10 holders included
BlackRock, Inc., Redmile Group, LLC, JPMORGAN CHASE & CO, VANGUARD GROUP INC, STATE STREET CORP, MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, Balyasny Asset Management L.P., DIMENSIONAL FUND ADVISORS LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
175
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.